Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients?

Semin Thromb Hemost. 2023 Feb;49(1):103-104. doi: 10.1055/s-0041-1742092. Epub 2022 Jan 12.

Authors

Sergio Carnevale¹, Marta Giovanetti², Domenico Benvenuto³, Massimo Ciccozzi³, Francesco Broccolo^{4

5}

Affiliations

¹ Cerba HealthCare Italia, Section of Anatomic Pathology, Milan, Italy.
² Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.
³ Medical Statistic and Molecular Epidemiology Unit, University of Biomedical Campus, Rome, Italy.
⁴ Department of Medicine and Surgery, School of Medicine, University of Milano-Bicocca, Monza, Italy.
⁵ Cerba HealthCare Italia, Milan, Italy.

PMID: 35021248
DOI: 10.1055/s-0041-1742092

No abstract available

MeSH terms

Autoimmunity
COVID-19*
Humans
Molecular Mimicry
SARS-CoV-2
Spike Glycoprotein, Coronavirus*

Substances

Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
ZNF85 protein, human